Glucotrack Shares Jump After USPTO Grants Three Patents for Implantable Glucose Monitor
Glucotrack Inc. (NASDAQ: GCTK) saw its stock surge 60% on Thursday following U.S. Patent and Trademark Office approval of three patents tied to its continuous blood glucose monitoring platform. The patents protect core elements of the company's fully implantable system as it moves toward further clinical testing and eventual commercialization.